ProKidney Corp.
ProKidney Corp. scores highest on Torque (57) and lowest on Price (0). Its PosiPenta is 35.77 out of 100, weaker than most similar companies.
On the Penta Grid this week, ProKidney Corp. is Grid #647 of 837 in the Healthcare sector in United States, and Grid #3,236 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| ProKidney Corp. | 35.77 | 0 | 40 | 27 | 57 | 54 |
| MiMedx Group, Inc. | 55.55 | 27 | 84 | 56 | 66 | 46 |
| Phathom Pharmaceuticals, Inc. | 49.53 | 0 | 66 | 30 | 95 | 58 |
| Aclaris Therapeutics, Inc. | 42.60 | 17 | 37 | 53 | 57 | 49 |
| Shattuck Labs, Inc. | 49.85 | 24 | 41 | 71 | 64 | 49 |
| Electra Therapeutics, Inc. | 35.43 | 0 | 26 | 41 | 68 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.42 |
| P/B ratio | -0.60 |
EEarnings
| Trailing EPS | ₹-52.09 |
| Forward EPS | ₹-55.55 |
NNitro
| Price | 125.97 |
| 52-week high | 329.61 |
| 52-week low | 123.13 |
| Fall from 52-week high | 61.8% |
TTorque
| Return on equity (ROE) | -58.96% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 1.80 |
| Market cap | ₹5,028 Cr |
| Insider holding | 46.45% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ProKidney Corp.'s PosiPenta score?
ProKidney Corp.'s PosiPenta is 35.77 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does ProKidney Corp. stand on the Penta Grid?
On the Penta Grid this week, ProKidney Corp. is Grid #647 of 837 in the Healthcare sector in United States, and Grid #3,236 of 4,000 in United States.
Which PosiPenta pillar is strongest for ProKidney Corp.?
Torque (durability), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for ProKidney Corp.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has ProKidney Corp.'s PosiPenta changed since last week?
Yes, it rose 2.36 points, from 33.41 to 35.77.
PositoAI is for research and education only and is not investment advice.